FIIs Bet on Growth Amidst Outflows: Banks, Hospitals, Marine Lead Picks
Overview
Despite a continued trend of Foreign Institutional Investors (FIIs) being net sellers in Indian equities during Q3FY26, a strategic reallocation of capital is evident. These 'smart money' flows are concentrating into select companies with strong growth narratives and long-term visibility, namely IDFC First Bank, Artemis Medicare Services, and Knowledge Marine & Engineering Works Ltd. This selective buying suggests FIIs are prioritizing specific catalysts over broader market sentiment, even as overall outflows persist.
Stocks Mentioned
FIIs Target Growth Catalysts Amidst Net Outflows
Foreign institutional investors (FIIs) extended their net selling in Indian equity markets, offloading ₹11,760 crore in the October-December 2025 quarter. This follows a more substantial ₹76,609 crore divestment in the preceding July-September quarter. However, this overall outflow masks a more nuanced strategy: increased exposure to specific companies demonstrating robust future growth prospects and unique market positions.
IDFC First Bank: Retail Banking's Transformation Play
IDFC First Bank saw a significant surge in FII interest, with stake increases totaling 12.12 percentage points, pushing total foreign holding to 36.8%. This accumulation, partly driven by preferential allotments to entities like Warburg Pincus and Abu Dhabi Investment Authority, signals conviction in the bank's retail-focused transformation. The bank reported solid Q2FY26 performance, with customer deposits growing 23.4% year-on-year to ₹2,69,094 crore and gross loans advancing 19.7% to ₹2,66,579 crore. Importantly, asset quality improved, with gross Non-Performing Assets (NPAs) declining to 1.86% from 1.97%. Despite a premium Price-to-Earnings (P/E) ratio of 49.1x, considerably higher than the banking sector median of approximately 14.88x, analysts at ICICI Securities maintain a 'BUY' rating with a target of ₹80, while Centrum Broking suggests 'REDUCE' with a target of ₹59. The stock has demonstrated resilience, gaining 42.32% over the past year, reflecting investor confidence in its strategic direction [13, 14]. Competitors like HDFC Bank and ICICI Bank trade at significantly lower P/E multiples [13].
Artemis Medicare: Expansion Fuels Healthcare Ambitions
Artemis Medicare Services attracted FII attention with a 12.1% point stake increase, reaching a total foreign holding of 12.47%. The International Finance Corporation was a notable buyer, acquiring an 11.98% stake. This enhanced institutional interest aligns with Artemis's ambitious brownfield and greenfield expansion plans, aiming to add 850 to 1,000 beds in the next 18 months through new facilities in Raipur and South Delhi. In Q2FY26, sales grew 15% year-on-year to ₹270 crore, with net profit up 32.8% to ₹30 crore. The stock's P/E of 39.3x is below the reported industry median of 46.5x, positioning it relatively attractively within the healthcare services sector [4]. However, its market capitalization stands at ₹3,751 crore, dwarfed by peers like Apollo Hospitals (₹98,922 crore) and Max Healthcare (₹94,907 crore) [4]. Despite positive profit growth over three years, the stock has underperformed the broader market and the healthcare industry over the past year, returning -18.68% [9].
KMEWL: Niche Dominance and Long-Term Contracts Drive Value
Knowledge Marine & Engineering Works Ltd. (KMEWL) witnessed a 10.26 percentage point increase in FII stake, bringing total holdings to 11%. This investment appears driven by the company's substantial order book, particularly a ₹650 crore Green Tug contract offering 15 years of revenue visibility and a ₹800 crore luxury cruise ship project. While these long-term contracts provide strategic advantages in a sector prioritizing green maritime operations, the company's Q2FY26 financials showed a marginal dip in sales to ₹50 crore and net profit to ₹12 crore. KMEWL trades at an elevated P/E of 81.7x, significantly above the Asian Shipping industry average P/E of 10.2x, and a high Price-to-Book (PB) ratio of 14.9x against an industry median of 8.6x [8, 12]. This valuation disconnect suggests significant investor expectations for future growth. Nuvama has initiated coverage with a target price of ₹2,500, indicating potential upside despite current valuation concerns [11]. The stock has seen robust growth, up 83.13% over the last year [11].
Valuation and Outlook: A Strategic Re-evaluation
The concentrated FII buying in these three disparate sectors highlights a shift towards companies with strong order books, clear expansion strategies, and long-term revenue visibility, often within niche market segments. While IDFC First Bank offers a re-rating story in a competitive banking space, Artemis Medicare leverages expansion in a growing healthcare sector, and KMEWL capitalizes on emerging green maritime opportunities. The premium valuations across these stocks, particularly for KMEWL, indicate that FIIs are looking beyond current earnings, betting on future execution and market positioning to justify current price levels. The sustained FII selling in the broader market suggests caution, but these selective investments could signal emerging opportunities for investors seeking specific growth narratives.
